(Q37357311)

19 August 2017

1 reference

title

Treatment of resectable gastric cancer: current standards of care (English)

1 reference

19 August 2017

author name string

Philip Abraham Kovoor

series ordinal

1

1 reference

19 August 2017

Jimmy Hwang

series ordinal

2

1 reference

19 August 2017

publication date

1 January 2009

1 reference

Expert Review of Anticancer Therapy

19 August 2017

published in

1 reference

19 August 2017

volume

9

1 reference

19 August 2017

issue

1

1 reference

19 August 2017

page(s)

135-142

1 reference

19 August 2017

cites work

Cancer statistics, 2008

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Poor housing in childhood and high rates of stomach cancer in England and Wales

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

A prospective study of dietary salt intake and gastric cancer incidence in a defined Japanese population: the Hisayama study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Pernicious anemia and subsequent cancer. A population-based cohort study

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Prospective study of screening for stomach cancer in Japan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Case-control study of gastric cancer screening in Venezuela

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Significant regional variation in adequacy of lymph node assessment and survival in gastric cancer.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Patient survival after D1 and D2 resections for gastric cancer: long-term results of the MRC randomized surgical trial. Surgical Co-operative Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Adjuvant chemotherapy after curative resection for gastric cancer in non-Asian patients: revisiting a meta-analysis of randomised trials

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Efficacy of adjuvant chemotherapy after curative resection for gastric cancer: a meta-analysis of published randomised trials. A study of the GISCAD (Gruppo Italiano per lo Studio dei Carcinomi dell'Apparato Digerente).

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Extracting summary statistics to perform meta-analyses of the published literature for survival endpoints

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

On the relationship between response to treatment and survival time

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Adjuvant chemotherapy for gastric cancer with S-1, an oral fluoropyrimidine

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Occult para-aortic lymph node metastasis after negative positron emission tomography/computed tomography scan.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

A controlled, prospective, randomised trial of adjuvant chemotherapy or radiotherapy in resectable gastric cancer: interim report. British Stomach Cancer Group

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

The impact of radiotherapy on survival in resectable gastric carcinoma: a meta-analysis of literature data.

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Chemoradiotherapy after surgery compared with surgery alone for adenocarcinoma of the stomach or gastroesophageal junction

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Perioperative chemotherapy versus surgery alone for resectable gastroesophageal cancer

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Phase II trial of preoperative chemoradiation in patients with localized gastric adenocarcinoma (RTOG 9904): quality of combined modality therapy and pathologic response

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

Lymph Node Staging in Gastric Cancer: Is Location More Important Than Number?

21 January 2018

1 reference

https://api.crossref.org/works/10.1586%2F14737140.9.1.135

21 January 2018

Identifiers

DOI

10.1586/14737140.9.1.135

1 reference

19 August 2017

1 reference